Tel: +421 8 005 00 589
Email: sk_infocentrum@gsk.com
Tel: +421 8 005 00 589
Email: sk-safety@gsk.com
Our Privacy Notice outlines how GSK handles the processing of personal information when dealing with your enquiry, complaint or adverse event report.
Please contact Berlin-Chemie Menarini
Tel: +421 2 544 30 730
Email: slovakia@berlin-chemie.com
Please contact Phoenix Group
Tel: +421 2 499 99 191
Please contact: WW.CEEurope-media@GSK.com
EFPIA disclosure
GSK fully supports the European Federation of Pharmaceutical Industries and Associations (EFPIA) Code on the disclosure of individual transfer of value from pharmaceutical companies to healthcare professionals and healthcare organisations
We believe that it helps to create a better understanding about how the pharmaceutical industry partners and collaborates with HCPs and HCOs, and so increase confidence in the way that industry and the healthcare professions work together.
We publish disclosure reports in line with the EFPIA Code on the disclosure of individual transfers of value from pharmaceutical companies to healthcare professionals and healthcare organisations.